Improvement in liver steatosis after the switch from a ritonavir-boosted protease inhibitor to raltegravir in HIV-infected patients with non-alcoholic fatty liver disease-Reference-Cited by-同舟云学术

Improvement in liver steatosis after the switch from a ritonavir-boosted protease inhibitor to raltegravir in HIV-infected patients with non-alcoholic fatty liver disease

Published:2019-06-20 Issue:8 Volume:51 Page:593-601
ISSN:2374-4235
Container-title:Infectious Diseases
language:en
Short-container-title:Infectious Diseases

Author:

Calza Leonardo¹,Colangeli Vincenzo¹,Borderi Marco¹,Coladonato Simona¹,Tazza Beatrice¹,Fornaro Giacomo¹,Badia Lorenzo¹,Guardigni Viola¹,Verucchi Gabriella¹,Viale Pierluigi¹

Affiliation:

1. Department of Medical and Surgical Sciences, Clinic of Infectious Diseases and Microbiology Unit*, “Alma Mater Studiorum”, University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/23744235.2019.1629008

Reference36 articles.

1. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

2. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

3. Epidemiology and Natural History of Non-Alcoholic Steatohepatitis

4. NAFLD: A multisystem disease

5. Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of weight gain and metabolic dysfunction-associated steatotic liver disease on liver fibrosis progression and regression in people with HIV;AIDS;2024-04-18

2. Regional variation in NAFLD prevalence and risk factors among people living with HIV in Europe: a meta-analysis;Frontiers in Public Health;2024-01-04

3. Impact of Combination Antiretroviral Treatment on Liver Metabolic Health in HIV-Infected Persons;Viruses;2023-12-15

4. Fatty Liver Disease: Enter the Metabolic Era;Current HIV/AIDS Reports;2023-10-26

5. Role of fatty liver in the epidemic of advanced chronic liver disease among people with HIV: protocol for the Canadian LIVEHIV multicentre prospective cohort;BMJ Open;2023-08